DNA methylation signatures in peripheral blood strongly predict all-cause mortality

Nature Communications

Volumn 8, Issue , 2017, Pages

  Zhang, Yan ^a   Wilson, Rory ^b   Heiss, Jonathan ^a   Breitling, Lutz P ^a   Saum, Kai Uwe ^a   Schöttker, Ben ^a,c   Holleczek, Bernd ^d   Waldenberger, Melanie ^b   Peters, Annette ^b   Brenner, Hermann ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d SAARLAND CANCER REGISTRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALRETININ; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; HLA ANTIGEN; HLA DMA ANTIGEN; PROTEIN BCL 3; SPACER DNA; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRANSCRIPTION FACTOR ETV6; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

CHEMICAL BONDING; DISEASE INCIDENCE; DNA; GENETIC ANALYSIS; GENETIC MARKER; HEALTH RISK; METHYLATION; MORTALITY;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD; BREAST CANCER; CANCER MORTALITY; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; CDC42BPB GENE; CLINICAL PRACTICE; CORONARY ARTERY DISEASE; CPG ISLAND; CRISPLD2 GENE; DNA METHYLATION; ENDOMETRIUM CANCER; EPIGENETICS; F2RL3 GENE; FEMALE; FOLLOW UP; GENE LOCUS; GENETIC ASSOCIATION; GENOME-WIDE ASSOCIATION STUDY; GLIOBLASTOMA; HAZARD RATIO; HUMAN; INPP5A GENE; KCNQ1OT1 GENE; KIDNEY CARCINOMA; LEUKEMIA; LIVER FIBROSIS; LUNG CANCER; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; MIDDLE AGED; MIR19A GENE; MKL1 GENE; MORTALITY; MPRIP GENE; MULTIPLE MYELOMA; MULTIPLE SCLEROSIS; NEUROPATHY; NFE2L3 GENE; OBESITY; OVARY CANCER; PARKINSON DISEASE; PDE9A GENE; PHYSICAL ACTIVITY; PROSTATE CANCER; RARA GENE; RISK ASSESSMENT; SHANK2 GENE; SLC1A5 GENE; SLC22A18AS GENE; SQLE GENE; SYSTEMIC SCLEROSIS; THYROID CARCINOMA; TMEM104 GENE; UNDERWEIGHT; CAUSE OF DEATH; COHORT ANALYSIS; DIABETES MELLITUS; GENETIC EPIGENESIS; GENETICS; HYPERTENSION; NEOPLASM; PROPORTIONAL HAZARDS MODEL; SMOKING;

AGED; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COHORT STUDIES; CPG ISLANDS; DIABETES MELLITUS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MORTALITY; NEOPLASMS; OBESITY; OVERWEIGHT; PROPORTIONAL HAZARDS MODELS; SMOKING; THINNESS;

EID: 85015616657     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms14617     Document Type: Article

References (63)

1. Dick, K. J. et al. DNA methylation and body-mass index: a genome-wide analysis. Lancet 383, 1990-1998 (2014)
2. Gao, X., Jia, M., Zhang, Y., Breitling, L. P. & Brenner, H. DNA methylation changes of whole blood cells in response to active smoking exposure in adults: a systematic review of DNA methylation studies. Clin. Epigenetics 7, 113 (2015)
3. Feinberg, A. P. Genome-scale approaches to the epigenetics of common human disease. Virchows Arch. 456, 13-21 (2010)
4. Zhong, J., Agha, G. & Baccarelli, A. A. The role of DNA methylation in cardiovascular risk and disease: methodological aspects, study design, and data analysis for epidemiological studies. Circ. Res. 118, 119-131 (2016)
5. Chambers, J. C. et al. Epigenome-wide association of DNA methylation markers in peripheral blood from Indian Asians and Europeans with incident type 2 diabetes: a nested case-control study. Lancet Diabetes Endocrinol. 3, 526-534 (2015)
6. Klengel, T., Pape, J., Binder, E. B. & Mehta, D. The role of DNA methylation in stress-related psychiatric disorders. Neuropharmacology 80, 115-132 (2014)
7. Dang, M. N., Buzzetti, R. & Pozzilli, P. Epigenetics in autoimmune diseases with focus on type 1 diabetes. Diabetes Metab. Res. Rev. 29, 8-18 (2013)
8. Zhang, Y. et al. Smoking-associated DNA methylation biomarkers and their predictive value for all-cause and cardiovascular mortality. Environ. Health Perspect. 124, 67-74 (2016)
9. Zhang, Y. et al. F2RL3 methylation, lung cancer incidence and mortality. Int. J. Cancer. 137, 1739-1748 (2015)
10. Zhang, Y. et al. F2RL3 methylation in blood DNA is a strong predictor of mortality. Int. J. Epidemiol. 43, 1215-1225 (2014)
11. Hannum, G. et al. Genome-wide methylation profiles reveal quantitative views of human aging rates. Mol. Cell 49, 359-367 (2013)
12. Horvath, S. DNA methylation age of human tissues and cell types. Genome Biol. 14, R115 (2013)
13. Marioni, R. E. et al. DNA methylation age of blood predicts all-cause mortality in later life. Genome Biol. 16, 25 (2015)
14. Breitling, L. P. et al. Frailty is associated with the epigenetic clock but not with telomere length in a German cohort. Clin. Epigenetics 8, 21 (2016)
15. Christiansen, L. et al. DNA methylation age is associated with mortality in a longitudinal Danish twin study. Aging Cell 15, 149-154 (2016)
16. Marioni, R. E. et al. The epigenetic clock and telomere length are independently associated with chronological age and mortality. Int. J. Epidemiol. 45, 424-432 (2016)
17. Lin, Q. et al. DNA methylation levels at individual age-associated CpG sites can be indicative for life expectancy. Aging (Albany NY) 8, 394-401 (2016)
18. Moore, A. Z. et al. Change in epigenome-wide DNA methylation over 9 years and subsequent mortality: results from the InCHIANTI Study. J. Gerontol. A Biol. Sci. Med. Sci. 71, 1029-1035 (2016)
19. Bell, J. T. et al. Epigenome-wide scans identify differentially methylated regions for age and age-related phenotypes in a healthy ageing population. PLoS Genet. 8, e1002629 (2012)
20. Marttila, S. et al. Ageing-associated changes in the human DNA methylome: genomic locations and effects on gene expression. BMC Genomics 16, 179 (2015)
21. Jung, M. & Pfeifer, G. P. Aging and DNA methylation. BMC Biol. 13, 7 (2015)
22. Florath, I., Butterbach, K., Müller, H., Bewerunge-Hudler, M. & Brenner, H. Cross-sectional and longitudinal changes in DNA methylation with age: an epigenome-wide analysis revealing over 60 novel age-associated CpG sites. Hum. Mol. Genet. 23, 1186-1201 (2014)
23. Weidner, C. I. et al. Aging of blood can be tracked by DNA methylation changes at just three CpG sites. Genome Biol. 15, R24 (2014)
24. Teschendorff, A. E. et al. Correlation of smoking-associated DNA methylation changes in buccal cells with DNA methylation changes in epithelial cancer. JAMA Oncol. 1, 476-485 (2015)
25. Al Muftah, W. A. et al. Epigenetic associations of type 2 diabetes and BMI in an Arab population. Clin. Epigenetics 8, 13 (2016)
26. Travers, M. E. et al. Insights into the molecular mechanism for type 2 diabetes susceptibility at the KCNQ1 locus from temporal changes in imprinting status in human islets. Diabetes 62, 987-992 (2013)
27. Nilsson, E. et al. Altered DNA methylation and differential expression of genes influencing metabolism and inflammation in adipose tissue from subjects with type 2 diabetes. Diabetes 63, 2962-2976 (2014)
28. Desquilbet, L. & Mariotti, F. Dose-response analyses using restricted cubic spline functions in public health research. Stat. Med. 29, 1037-1057 (2010)
29. Zhang, Y., Yang, R., Burwinkel, B., Breitling, L. P. & Brenner, H. F2RL3 methylation as a biomarker of current and lifetime smoking exposures. Environ. Health Perspect. 122, 131-137 (2014)
30. Guida, F. et al. Dynamics of smoking-induced genome-wide methylation changes with time since smoking cessation. Hum. Mol. Genet. 24, 2349-2359 (2015)
31. Do, H. et al. A critical re-assessment of DNA repair gene promoter methylation in non-small cell lung carcinoma. Sci. Rep. 4, 4186 (2014)
32. Singh, K. P., Treas, J., Tyagi, T. & Gao, W. DNA demethylation by 5-aza-2- deoxycytidine treatment abrogates 17 beta-estradiol-induced cell growth and restores expression of DNA repair genes in human breast cancer cells. Cancer Lett. 316, 62-69 (2012)
33. Marchetti, G. et al. An integrated genomic-transcriptomic approach supports a role for the proto-oncogene BCL3 in atherosclerosis. Thromb. Haemost. 113, 655-663 (2015)
34. Lu, W. et al. MCPIP1 selectively destabilizes transcripts associated with an antiapoptotic gene expression program in breast cancer cells that can elicit complete tumor regression. Cancer Res. 76, 1429-1440 (2016)
35. Ahlqvist, K., Saamarthy, K., Syed Khaja, A. S., Bjartell, A. & Massoumi, R. Expression of Id proteins is regulated by the Bcl-3 proto-oncogene in prostate cancer. Oncogene 32, 1601-1608 (2013)
36. Bhutia, Y. D., Babu, E., Ramachandran, S. & Ganapathy, V. Amino Acid transporters in cancer and their relevance to glutamine addiction: novel targets for the design of a new class of anticancer drugs. Cancer Res. 75, 1782-1788 (2015)
37. Honjo, Y. et al. Increased GADD34 in oligodendrocytes in Alzheimers disease. Neurosci. Lett. 602, 50-55 (2015)
38. Morton, E., Macrae, I. M., McCabe, C., Brown, S. M. & White, F. Identification of the growth arrest and DNA damage protein GADD34 in the normal human heart and demonstration of alterations in expression following myocardial ischaemia. Int. J. Cardiol. 107, 126-129 (2006)
39. Nishio, N. & Isobe, K. GADD34-deficient mice develop obesity, nonalcoholic fatty liver disease, hepatic carcinoma and insulin resistance. Sci. Rep. 5, 13519 (2015)
40. Ding, J. et al. Alterations of a cellular cholesterol metabolism network are a molecular feature of obesity-related type 2 diabetes and cardiovascular disease. Diabetes 64, 3464-3474 (2015)
41. Dayeh, T. et al. Genome-wide DNA methylation analysis of human pancreatic islets from type 2 diabetic and non-diabetic donors identifies candidate genes that influence insulin secretion. PLoS Genet. 10, e1004160 (2014)
42. Kriebel, J. et al. Association between DNA methylation in whole blood and measures of glucose metabolism: KORA F4 Study. PLoS ONE 11, e0152314 (2016)
43. Vausort, M., Wagner, D. R. & Devaux, Y. Long noncoding RNAs in patients with acute myocardial infarction. Circ. Res. 115, 668-677 (2014)
44. Parris, T. Z. et al. Frequent MYC coamplification and DNA hypomethylation of multiple genes on 8q in 8p11-p12-amplified breast carcinomas. Oncogenesis 3, e95 (2014)
45. Sunamura, N. et al. Regulation of functional KCNQ1OT1 lncRNA by beta-catenin. Sci. Rep. 6, 20690 (2016)
46. Chen, X. et al. Analysis of DNA methylation and gene expression in radiationresistant head and neck tumors. Epigenetics 10, 545-561 (2015)
47. Walter, S. et al. A genome-wide association study of aging. Neurobiol. Aging 32, e28 (2011)
48. Hallden, S. et al. Smoking and obesity associated BDNF gene variance predicts total and cardiovascular mortality in smokers. Heart 99, 949-953 (2013)
49. Lee, S. J., Go, A. S., Lindquist, K., Bertenthal, D. & Covinsky, K. E. Chronic conditions and mortality among the oldest old. Am. J. Public Health 98, 1209-1214 (2008)
50. Houseman, E. A. et al. DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinformatics 13, 86 (2012)
51. Schöttker, B. et al. Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study. Am. J. Clin. Nutr. 97, 782-793 (2013)
52. Holle, R., Happich, M., Lowel, H. & Wichmann, H. E. MONICA/KORA Study Group. KORA--a research platform for population based health research. Gesundheitswesen 67, S19-S25 (2005)
53. Zeilinger, S. et al. Tobacco smoking leads to extensive genome-wide changes in DNA methylation. PLoS ONE 8, e63812 (2013)
54. Zhang, Y., Florath, I., Saum, K. U. & Brenner, H. Self-reported smoking, serum cotinine, and blood DNA methylation. Environ. Res. 146, 395-403 (2016)
55. Chen, Y. A. et al. Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray. Epigenetics 8, 203-209 (2013)
56. Lehne, B. et al. A coherent approach for analysis of the Illumina HumanMethylation450 BeadChip improves data quality and performance in epigenome-wide association studies. Genome Biol. 16, 37 (2015)
57. Smyth, G. in Bioinformatics and Computational Biology Solutions Using R and Bioconductor (eds Gentleman, R. et al.) 397-420 (Springer, 2005)
58. Barlow, W. E. Robust variance estimation for the case-cohort design. Biometrics 50, 1064-1072 (1994)
59. Kulathinal, S., Karvanen, J., Saarela, O. & Kuulasmaa, K. Case-cohort design in practice - experiences from the MORGAM Project. Epidemiol. Perspect. Innov. 4, 15 (2007)
60. Tibshirani, R. The lasso method for variable selection in the Cox model. Stat. Med. 16, 385-395 (1997)
61. Friedman, J., Hastie, T. & Tibshirani, R. Regularization paths for generalized linear models via coordinate descent. J. Stat. Softw. 33, 1-22 (2010)
62. Hastie, T., Tibshirani, R. & Friedman, J. The Elements of Statistical Learning 2nd edn (Springer, 2009)
63. Lin, D., Wei, L. & Ying, Z. Checking the Cox model with cumulative sums of martingale-based residuals. Biometrika 80, 557-572 (1993)